Akari Therapeutics Other Long Term Assets (Quarterly) Insights

Akari Therapeutics Plc (AKTX)

0.2639 -0.02 (-5.95%) USD | NASDAQ | Jan 20, 16:00

0.287 +0.02 (+8.75%) After-Hours: 05:31

View Other Long Term Assets (Quarterly) for AKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

DBV Technologies SA	Upgrade
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	--
NuCana Plc	--
Autolus Therapeutics Plc	Upgrade